376 related articles for article (PubMed ID: 31179586)
1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation.
Santos García D; Jesús S; Aguilar M; Planellas LL; García Caldentey J; Caballol N; Legarda I; Hernández Vara J; Cabo I; López Manzanares L; González Aramburu I; Ávila Rivera MA; Catalán MJ; López Díaz L; Puente V; García Moreno JM; Borrué C; Solano Vila B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Carrillo Padilla F; Martínez Castrillo JC; Sánchez Alonso P; Alonso Losada MG; López Ariztegui N; Gastón I; Kulisevsky J; Menéndez González M; Seijo M; Rúiz Martínez J; Valero C; Kurtis M; de Fábregues-Boixar O; González Ardura J; Prieto Jurczynska C; Martinez-Martin P; Mir P;
Eur J Neurol; 2019 Nov; 26(11):1399-1407. PubMed ID: 31179586
[TBL] [Abstract][Full Text] [Related]
2. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
[TBL] [Abstract][Full Text] [Related]
3. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
[TBL] [Abstract][Full Text] [Related]
4. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
Catalan MJ; Molina-Arjona JA; Mir P; Cubo E; Arbelo JM; Martinez-Martin P;
J Neurol; 2018 Jun; 265(6):1279-1287. PubMed ID: 29557989
[TBL] [Abstract][Full Text] [Related]
5. Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.
Hinkle JT; Perepezko K; Rosenthal LS; Mills KA; Pantelyat A; Mari Z; Tochen L; Bang JY; Gudavalli M; Yoritomo N; Butala A; Bakker CC; Johnson V; Moukheiber E; Dawson TM; Pontone GM
Parkinsonism Relat Disord; 2018 Feb; 47():50-56. PubMed ID: 29198499
[TBL] [Abstract][Full Text] [Related]
6. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort.
Santos García D; de Deus Fonticoba T; Suárez Castro E; Borrué C; Mata M; Solano Vila B; Cots Foraster A; Álvarez Sauco M; Rodríguez Pérez AB; Vela L; Macías Y; Escalante S; Esteve P; Reverté Villarroya S; Cubo E; Casas E; Arnaiz S; Carrillo Padilla F; Pueyo Morlans M; Mir P; Martinez-Martin P;
Parkinsonism Relat Disord; 2019 Sep; 66():151-157. PubMed ID: 31409572
[TBL] [Abstract][Full Text] [Related]
7. Depression is Associated with Impulse-compulsive Behaviors in Parkinson's disease.
Santos-García D; de Deus Fonticoba T; Cores Bartolomé C; Suárez Castro E; Jesús S; Mir P; Pascual-Sedano B; Pagonabarraga J; Kulisevsky J; Hernández-Vara J; Planellas LL; Cabo-López I; Seijo-Martínez M; Legarda I; Carrillo Padilla F; Caballol N; Cubo E; Nogueira V; Alonso Losada MG; López Ariztegui N; González Aramburu I; García Caldentey J; Borrue C; Valero C; Sánchez Alonso P;
J Affect Disord; 2021 Feb; 280(Pt B):77-89. PubMed ID: 33242731
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical profile of Parkinson's disease between Spanish and Cameroonian cohorts.
Cubo E; Doumbe J; Martinez-Martin P; Rodriguez-Blazquez C; Kuate C; Mariscal N; Lopez I; Noubissi G; Mapoure YN; Jon JL; Mbahe S; Tchaleu B; Catalan MJ;
J Neurol Sci; 2014 Jan; 336(1-2):122-6. PubMed ID: 24183853
[TBL] [Abstract][Full Text] [Related]
9. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
[TBL] [Abstract][Full Text] [Related]
10. Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.
Lee PC; Artaud F; Cormier-Dequaire F; Rascol O; Durif F; Derkinderen P; Marques AR; Bourdain F; Brandel JP; Pico F; Lacomblez L; Bonnet C; Brefel-Courbon C; Ory-Magne F; Grabli D; Klebe S; Mangone G; You H; Mesnage V; Brice A; Vidailhet M; Corvol JC; Elbaz A;
Mov Disord; 2019 Nov; 34(11):1663-1671. PubMed ID: 31518456
[TBL] [Abstract][Full Text] [Related]
11. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
Antonini A; Barone P; Bonuccelli U; Annoni K; Asgharnejad M; Stanzione P
J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):317-324. PubMed ID: 28315845
[TBL] [Abstract][Full Text] [Related]
12. Predictors of health-related quality of life in Parkinson's disease.
Kuhlman GD; Flanigan JL; Sperling SA; Barrett MJ
Parkinsonism Relat Disord; 2019 Aug; 65():86-90. PubMed ID: 31118162
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of neuropsychiatric disorders in drug-naive subjects with Parkinson's disease (PD)].
Isais-Millán S; Piña-Fuentes D; Guzmán-Astorga C; Cervantes-Arriaga A; Rodríguez-Violante M
Gac Med Mex; 2016; 152(3):357-63. PubMed ID: 27335192
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mood and Behavioral Disorders on Quality of Life in Parkinson's disease.
Rieu I; Houeto JL; Pereira B; De Chazeron I; Bichon A; Chéreau I; Ulla M; Brefel-Courbon C; Ory-Magne F; Dujardin K; Tison F; Krack P; Durif F
J Parkinsons Dis; 2016; 6(1):267-77. PubMed ID: 27003781
[TBL] [Abstract][Full Text] [Related]
15. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
Santos-García D; de la Fuente-Fernández R
J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease.
Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F
J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408
[TBL] [Abstract][Full Text] [Related]
17. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
[TBL] [Abstract][Full Text] [Related]
18. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
Bjornestad A; Forsaa EB; Pedersen KF; Tysnes OB; Larsen JP; Alves G
Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
[TBL] [Abstract][Full Text] [Related]
19. The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life.
Antonini A; Barone P; Marconi R; Morgante L; Zappulla S; Pontieri FE; Ramat S; Ceravolo MG; Meco G; Cicarelli G; Pederzoli M; Manfredi M; Ceravolo R; Mucchiut M; Volpe G; Abbruzzese G; Bottacchi E; Bartolomei L; Ciacci G; Cannas A; Randisi MG; Petrone A; Baratti M; Toni V; Cossu G; Del Dotto P; Bentivoglio AR; Abrignani M; Scala R; Pennisi F; Quatrale R; Gaglio RM; Nicoletti A; Perini M; Avarello T; Pisani A; Scaglioni A; Martinelli PE; Iemolo F; Ferigo L; Simone P; Soliveri P; Troianiello B; Consoli D; Mauro A; Lopiano L; Nastasi G; Colosimo C
J Neurol; 2012 Dec; 259(12):2621-31. PubMed ID: 22711157
[TBL] [Abstract][Full Text] [Related]
20. Relationship between pain and motor and non-motor symptoms in Parkinson's disease.
Defazio G; Antonini A; Tinazzi M; Gigante AF; Pietracupa S; Pellicciari R; Bloise M; Bacchin R; Marcante A; Fabbrini G; Berardelli A
Eur J Neurol; 2017 Jul; 24(7):974-980. PubMed ID: 28516474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
